 CAMBRIDGE, Mass., Oct. 29, 2020 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. NASDAQ:AGIO, a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a webinar focused on its pyruvate kinase-R PKR activation clinical programs and the commercial outlook across three distinct hemolytic anemias on Thursday, November 19, 2020 from 8:00 a.m. to 10:30 a.m. ET. 